Pricing

Novo-Nordisk A/S ADS (NVO)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Lars F. Jørgensen
Employees: 54,400
Web site: novonordisk.com
NOVO ALLE DK 2880, BAGSVAERD DENMARK, G7, 00000
4544448888
Stock Split History
Date Ratio
2001-04-11 2.5000
2007-12-17 2:1
2014-01-09 5:1
2023-09-20 2:1
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Novo Nordisk A/S engages in the research, development, manufacture, and marketing of pharmaceutical products. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in areas of haemophilia, growth disorders, and hormone replacement therapy. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available